Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
fda
5
×
life sciences
loxo oncology
5
×
national blog main
san francisco blog main
biotech
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
black diamond therapeutics
blueprint medicines
cancer drugs
crispr therapeutics
deals
eli lilly
gene editing
glaxosmithkline
ipo
What
cancer
5
×
drug
new
roundup
bio
biotech
black
cash
ipo
targets
therapeutics
ahead
allogene
ambien
american
annual
appetite
approved
asco
attendees
attention
bread
butter
buyout
camp’s
chicago
city
clinic
clinical
combinations
community’s
companies
crispr
days
deeper
diabetes
diamond
diamond’s
diversity
dna
Language
unset
Current search:
fda
×
cancer
×
" loxo oncology "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More